表紙:感染対策の世界市場
市場調査レポート
商品コード
997485

感染対策の世界市場

Infection Control

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 388 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.34円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

感染対策の世界市場
出版日: 2022年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 388 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の感染対策の市場規模は、分析期間(2020年~2027年)に5.1%のCAGRで成長する見通しで、2020年の169億米ドルから、2027年には240億米ドルに達すると予測されています。

当レポートで分析されているセグメントの1つである消毒製品は、分析期間中に5.8%のCAGRで成長し、161億米ドルに達すると予測されています。

当レポートは、世界の感染対策市場について調査しており、Covid-19の影響、動向や成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • 3M Company
  • Advanced Sterilization Products
  • Belimed AG
  • Cantel Medical Corporation
  • Ecolab, Inc.
  • Getinge AB (Getinge Group)
  • Halyard Health, Inc.
  • Matachana Group
  • Metrex Research LLC
  • Pal International Ltd.
  • Reckitt Benckiser Group PLC
  • Sotera Health LLC
  • Steris

目次

I. 調査手法

II. エグゼクティブサマリー

  • 市場概要
    • インフルエンサー市場の洞察
    • 世界市場の軌跡
    • 感染管理市場:序文
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と推進要因
    • 表面消毒剤の市場動向
    • 感染管理市場推進要因の要約
    • 高齢人口増加による市場成長への拍車
    • 院内感染の発生率の上昇による感染管理の需要への拍車
    • 滅菌装置の技術的進歩による感染管理市場の近代化
    • 院内感染を最小限に抑えるUV消毒の市場拡大
    • ガイドラインと基準
    • イノベーション
    • 健康障害の発生率の増加による北米市場の牽引
  • 世界市場の見通し

III. 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

IV. 競合

  • 企業プロファイル:41社
目次
Product Code: MCP12704

Global Infection Control Market to Reach US$62.3 Billion by the Year 2026

Infection control plays a critical role in activities related to sterile processing of devices, in addition to disposal and decontamination of potentially infectious bio-hazardous waste. The market for infection control is expected to witness rapid growth in the coming years due to the rapidly growing incidence of HAIs (Hospital Acquired Infections) and rising number of surgeries. Healthcare Associated Infections (HAIs) constitute one of the leading causes of death globally and constitutes for nearly 100,000 deaths every year in the US alone. Other market growth promoting factors include rising geriatric population, especially in developed countries, and increasing prevalence of chronic diseases. Market growth is also being positively influenced by the rising focus of nations on disinfection and sterilization. Pharmaceutical companies, medical device companies and hospitals are also increasingly outsourcing such sterilization jobs, which is also contributing to market growth. The market is witnessing the development of advanced sterilization equipment in response to the advanced medical equipment being developed. Factors, such as increasing public and professional awareness, need for reducing healthcare costs, shifting of patient care from acute care to alternate sites, growth of less invasive surgical and diagnostic procedures, and the rising number of transmittable and antibiotic-resistant infectious diseases, have led to the increased demand for safe and efficient sterilization equipment.

Amid the COVID-19 crisis, the global market for Infection Control estimated at US$40.3 Billion in the year 2020, is projected to reach a revised size of US$62.3 Billion by 2026, growing at a CAGR of 7.2% over the analysis period. Protective Barriers, one of the segments analyzed in the report, is projected to grow at a 9.2% CAGR to reach US$26.1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sterilization Products & Services segment is readjusted to a revised 7.2% CAGR for the next 7-year period. Growing demand for surgical drapes, gowns and face masks and such other medical nonwovens, amid the pandemic, has been contributing to growth of protective barriers.

The U.S. Market is Estimated at $12.9 Billion in 2021, While China is Forecast to Reach $9.2 Billion by 2026

The Infection Control market in the U.S. is estimated at US$12.9 Billion in the year 2021. The country currently accounts for a 27.5% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$9.2 Billion in the year 2026 trailing a CAGR of 8.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR while Rest of European market (as defined in the study) will reach US$3.4 Billion by the end of the analysis period. North America is the largest regional market for infection control attributed to increased adoption of disinfection and sterilization products and services and also increased focus of the population here on disease prevention and following healthy lifestyles. Another lucrative market for infection control is Asia-pacific where increasing HAIs incidence, especially in fast emerging countries, is leading to increased adoption of disinfection and sterilization equipment and services.

Cleaning & Disinfection Products Segment to Reach $10.5 Billion by 2026

In the global Cleaning & Disinfection Products segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.9 Billion in the year 2020 will reach a projected size of US$8.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1 Billion by the year 2026.

Select Competitors (Total 145 Featured) -

  • 3M Company
  • Advanced Sterilization Products
  • Belimed AG
  • Cantel Medical Corporation
  • Ecolab, Inc.
  • Getinge AB (Getinge Group)
  • Halyard Health, Inc.
  • Matachana Group
  • Metrex Research LLC
  • Pal International Ltd.
  • Reckitt Benckiser Group PLC
  • Sotera Health LLC
  • Steris

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • The Never-Ending "Race" Between the Virus & Vaccines Continues. Amidst this Chaotic Battle, Where is the World Economy Heading Now & Beyond?
    • Omicron Spreads Panic Worldwide; Omicron Variant Brings Back Memories & Fears of the Worst Part of the 2020 Pandemic
    • EXHIBIT 1: Time is of Essence! What We Know So Far - "Vaccine Efficiency against New Strains is Decreasing"
    • South Africa: Omicron's Origin Location
    • Short-term Impact of Omicron on Travel
    • Financial Impact
    • Scientists Seek to Gather More Information on Omicron
    • Pharma Firms Aim to Improve Existing Vaccines to Counter Omicron
    • Omicron: Impact on Travel Industry
    • Steps taken by the Countries to Prevent Transmission of Omicron Variant
    • With IMF Making an Upward Revision of Global GDP for 2021, Companies Are Bullish About an Economic Comeback Despite a Continuing Pandemic
    • EXHIBIT 2: A Strong Yet Exceedingly Patchy & Uncertain Recovery Shaped by New Variants Comes Into Play: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • Impact of COVID-19 on Infection Control Market
    • Global Market Analysis and Prospects
    • Product and End-use Segments
    • Regional Market Analysis
    • Market Growth Restraining Factors
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Sterilization Equipment Market Witnesses Rapid Growth
    • Major Players in the Global Sterilization Equipment Market
    • Low-Temperature Sterilization Gains Ground
    • Leading Players in the Low-Temperature Sterilization Market
    • Emergence of Outsourcing Trend Bodes Well for Sterilization Services
    • E-beam Sterilization of Medical Devices Registers Rapid Growth
    • Endoscope Contamination - A Major Health Hazard Driving the Demand for Sterilization Equipment
    • Increasing Need to Reduce Hospital-Acquired Infections Propel Market Demand
    • EXHIBIT 3: Leading Nosocomial Infections in the US: Percentage Breakdown of Healthcare Cost by Infection Type
    • EXHIBIT 4: Central Line-Associated Bloodstream Infection (CLABSI) SIR in the US Hospitals: 2010 to 2016
    • EXHIBIT 5: Catheter-associated Urinary Tract Infection (CAUTI) SIR in the US Hospitals: 2010 to 2016
    • EXHIBIT 6: Surgical Site Infections SIR of Abdominal Hysterectomy in the US Hospitals: 2010-2021
    • Government Support to Ensure Infection Control in Clinical Settings to Boost Demand for Infection Control Products
    • Increasing Prevalence of Chronic Disorders, Rise in Surgical Procedures and the Need to Prevent Transmission of Infections Fuels Market Growth
    • EXHIBIT 7: No. of Surgical Procedures in Aging Population in the US (2016, 2018 & 2022)
    • Aging Population - A Key Growth Driver
    • EXHIBIT 8: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Rising Demand for Medical Devices Augurs Well for the Market
    • COVID-19 Pandemic Triggers the Onset of Face Mask Era
    • Respirator Mask Records Significant Growth
    • Designers Revamp Face Masks into a Fashion Accessory
    • Surgical Drapes and Gowns: Indispensable for Safe Healthcare
    • Surgical Gowns Market: Stable Growth Outlook
    • High Demand for Disposable Drapes and Gowns
    • COVID-19 Outbreak Resulted in Massive Spike in Disposable Gloves Market
    • Growth in Medical Device Reprocessing to Offer New Areas of Growth
    • UV Disinfection Soaks up Limelight with COVID-19-Induced Disinfection Focus
    • Improving Healthcare Expenditure to Bode Well for Market Growth
    • EXHIBIT 9: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Technological Advancements
    • India Focuses on Development of COVID-19 Relevant Technologies for Disinfection and Sterilization
    • Sealive's Biovector Sterilization Technology for more Effective Inactivation of Viruses and Microorganisms
    • Introduction of Business-Friendly Policies and Guidelines Fuel Demand for Eco-Friendly Medical Sterilization Equipment
    • Challenges and Future Prospects
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
    • TABLE 4: World Current & Future Analysis for Protective Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Protective Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Protective Barriers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 7: World Current & Future Analysis for Sterilization Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Sterilization Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Sterilization Products & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 10: World Current & Future Analysis for Cleaning & Disinfection Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Cleaning & Disinfection Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Cleaning & Disinfection Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 13: World Current & Future Analysis for Endoscope Reprocessing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Endoscope Reprocessing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Endoscope Reprocessing Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 16: World Current & Future Analysis for Other Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Other Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Products & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 19: World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 22: World Current & Future Analysis for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Pharma & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 25: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 28: USA Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 31: USA Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • CANADA
    • TABLE 34: Canada Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 37: Canada Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • JAPAN
    • TABLE 40: Japan Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 43: Japan Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Japan Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Japan 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • CHINA
    • TABLE 46: China Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 49: China Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: China Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: China 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • EUROPE
    • TABLE 52: Europe Current & Future Analysis for Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
    • TABLE 55: Europe Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 58: Europe Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Europe Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Europe 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • FRANCE
    • TABLE 61: France Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 64: France Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: France Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: France 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • GERMANY
    • TABLE 67: Germany Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 70: Germany Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Germany Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Germany 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • ITALY
    • TABLE 73: Italy Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 76: Italy Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Italy Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Italy 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • UNITED KINGDOM
    • TABLE 79: UK Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 82: UK Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: UK Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: UK 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • SPAIN
    • TABLE 85: Spain Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Spain Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Spain 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 88: Spain Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Spain Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Spain 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • RUSSIA
    • TABLE 91: Russia Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Russia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Russia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 94: Russia Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Russia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Russia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF EUROPE
    • TABLE 97: Rest of Europe Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of Europe Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of Europe 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 100: Rest of Europe Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Rest of Europe Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Rest of Europe 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • ASIA-PACIFIC
    • TABLE 103: Asia-Pacific Current & Future Analysis for Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 104: Asia-Pacific Historic Review for Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Asia-Pacific 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
    • TABLE 106: Asia-Pacific Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Asia-Pacific Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Asia-Pacific 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 109: Asia-Pacific Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Asia-Pacific Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: Asia-Pacific 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • AUSTRALIA
    • TABLE 112: Australia Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Australia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Australia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 115: Australia Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Australia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Australia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • INDIA
    • TABLE 118: India Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: India Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: India 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 121: India Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: India Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: India 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • SOUTH KOREA
    • TABLE 124: South Korea Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: South Korea Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: South Korea 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 127: South Korea Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: South Korea Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: South Korea 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 130: Rest of Asia-Pacific Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Asia-Pacific Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of Asia-Pacific 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 133: Rest of Asia-Pacific Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Asia-Pacific Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Asia-Pacific 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • LATIN AMERICA
    • TABLE 136: Latin America Current & Future Analysis for Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 137: Latin America Historic Review for Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Latin America 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
    • TABLE 139: Latin America Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Latin America Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Latin America 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 142: Latin America Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Latin America Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Latin America 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • ARGENTINA
    • TABLE 145: Argentina Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Argentina Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Argentina 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 148: Argentina Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Argentina Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Argentina 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • BRAZIL
    • TABLE 151: Brazil Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Brazil Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Brazil 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 154: Brazil Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Brazil Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Brazil 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • MEXICO
    • TABLE 157: Mexico Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Mexico Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Mexico 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 160: Mexico Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Mexico Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: Mexico 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF LATIN AMERICA
    • TABLE 163: Rest of Latin America Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Rest of Latin America Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: Rest of Latin America 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 166: Rest of Latin America Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: Rest of Latin America Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: Rest of Latin America 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • MIDDLE EAST
    • TABLE 169: Middle East Current & Future Analysis for Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 170: Middle East Historic Review for Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: Middle East 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
    • TABLE 172: Middle East Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: Middle East Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: Middle East 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 175: Middle East Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Middle East Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: Middle East 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • IRAN
    • TABLE 178: Iran Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Iran Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: Iran 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 181: Iran Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Iran Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Iran 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • ISRAEL
    • TABLE 184: Israel Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Israel Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Israel 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 187: Israel Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Israel Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Israel 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • SAUDI ARABIA
    • TABLE 190: Saudi Arabia Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Saudi Arabia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Saudi Arabia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 193: Saudi Arabia Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Saudi Arabia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Saudi Arabia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 196: UAE Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: UAE Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: UAE 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 199: UAE Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: UAE Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: UAE 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • REST OF MIDDLE EAST
    • TABLE 202: Rest of Middle East Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Rest of Middle East Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Rest of Middle East 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 205: Rest of Middle East Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Rest of Middle East Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Rest of Middle East 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027
  • AFRICA
    • TABLE 208: Africa Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Africa Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Africa 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2012, 2021 & 2027
    • TABLE 211: Africa Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Africa Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Africa 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2012, 2021 & 2027

IV. COMPETITION

  • Total Companies Profiled: 145